Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 06, 2015 6:33 PM ET

Company Overview of Illinois Biotechnology Industry Organization

Company Overview

Illinois Biotechnology Industry Organization is based in the United States.

177 North State Street

Suite 500

Chicago, IL 60601

United States





Key Executives for Illinois Biotechnology Industry Organization

Chief Executive Officer and President
Vice Chairman of Human Health
Executive Director
Vice Chairman of Human Health and Director
Vice Chairman of Food & Agriculture and Director
Compensation as of Fiscal Year 2015.

Illinois Biotechnology Industry Organization Key Developments

Illinois Biotechnology Industry Organization and iBIO Institute Appoint Warren Ribley as President & CEO

The Illinois Biotechnology Industry Organization and its affiliate, the iBIO Institute announced that Warren Ribley has been named President & CEO of both organizations. He will assume his new responsibilities at the beginning of February 2015. Appointed to lead the Illinois Medical District in April of 2012, Ribley is widely credited with revitalizing the District and attracting new tenants and life sciences developments, including the University of Illinois’ Health Technology Innovation center (HTI). Ribley succeeds outgoing iBIO and iBIO Institute President & CEO, David Miller, who has led the iBIO organizations for over twelve years and last year announced his plans to retire in early 2015.

Illinois Biotechnology Industry Organization Announces Board Appointments

The Illinois Biotechnology Industry Organization (iBIO) announced the election of new additions to its board of directors. The new Board members, who include senior executives, policy, and investment experts from globally recognized corporations, add depth and prestige to an already-strong lineup of medical, agricultural, and industrial biotech representation. Joining iBIO’s board are Daniel Brennan of Lundbeck US, Jamie Oldani of Eli Lilly, Susanne Resatz of Vetter Development Services USA and Geeta Vemuri of Baxter Ventures. Daniel Brennan is vice president and general manager of Neurology and Business Development for Lundbeck US. Jamie Oldani serves as the Midwest Director of State Government Affairs for Eli Lilly and Company. Susanne Resatz, Ph.D., President of Vetter Development Services USA Inc., heads Vetter’s clinical manufacturing facility in suburban Chicago, Illinois. Geeta Vemuri joined Baxter in January 2012 as Vice President, Head of Baxter Ventures, the corporation's $200 million venture fund.

Illinois Biotechnology Industry Organization Announces Management Appointments

The Illinois Biotechnology Industry Organization (iBIO) has announced the election of Andy Hull as chairman of the iBIO Board of Directors, and the election of Linda Friedman, as chairperson of the iBIO Institute Board of Directors. As Vice President of Global Alliance Management for Takeda Pharmaceuticals, Hull is responsible for maximizing the success of Takeda's growing number of commercial and research and development partnerships. Hull has substantial experience in the biotech industry, with a focus on marketing, commercial development and partnerships. Before joining Takeda in 2002, Hull worked at Immunex as a Vice President of Specialty Therapeutics Marketing and at Abbott Laboratories in sales and marketing. Linda Friedman has been with Astellas US LLC and its predecessor companies since 1993. As Senior Vice President and General Counsel, she is responsible for legal, compliance, and internal audit for the Americas region, along with intellectual property for the U.S. Friedman has been a member of the Board of Directors for two years and has been a strong supporter of PROPEL and EDUCATE. She has been an active member of the PhRMA law section and chaired the Law Section Executive Committee in 2006-2007. iBIO also named Joe Nolan, chief commercial officer of Lundbeck Inc. as vice chair of human health; and Robb Leming, senior finance manager - Heartland Business Unit of DuPont Pioneer, as vice chairman for food and agriculture. iBIO also elected as new board members Percival Barretto-Ko, senior vice president of corporate strategy and government affairs, Astellas US; and Claudia Roth, PhD, president of Vetter Development Services USA Inc.

Similar Private Companies By Industry

Company Name Region
Danny R Simms CPA United States
Bw Acquisition Corp United States
LUXR, Ltd. United States
First Alarm Security & Patrol, Inc. United States
Com-Pac International, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Illinois Biotechnology Industry Organization, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at